Biogen: Canaccord Genuity raises target price to $272 from $248
BIIB•Canaccord Genuity raised its target price on Biogen to $272 from $248.
Related News
Ambev board approves buyback of up to 190 million shares
ABEV•
Biogen: TD Cowen raises target price to $260 from $250
BIIB•
Glaukos Corporation: BTIG raises target price to $234 from $205
GKOS•
Alphabet: D.A. Davidson cuts target price to $300
GOOGL•
NBT Bancorp Inc.: D.A. Davidson raises target price to $62 from $59
NBTB•